HANOI -- Temasek-backed Vertex Ventures announced that its venture capital arm focused on health care, Vertex Ventures HC (VVHC), has launched a $200 million Fund III to support life science and medical technology companies.
VVHC, a women-led health care investment firm, will seek investment opportunities in early-stage companies that demonstrate disruptive technologies, breakthrough research and a clear path toward developing new medicines for patients.
